Weight-loss drugs Wegovy and Mounjaro to be reimbursed in France from Monday

AI justification

[Auto-resolved by learned corrector: learned-map — A=BURN/B=NEUTRAL -> BURN (human chose this in 89% of 85 past reviews)] Reimbursement policy advances public health by improving access to obesity treatment. | The French government's decision to reimburse weight-loss drugs for severe obesity cases directly advances SDG 3 (Good Health and Well-being) by improving access to evidence-based treatment. The requirement for specialized prescriptions adds a safeguard against misuse, enhancing the ethica